GLYC — GlycoMimetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for GlycoMimetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	158	137	90.3	47.9	41.8
Net Total Receivables	0.186	0.002	0.001	0.144	0.176
Prepaid Expenses
Total Current Assets	163	138	90.8	50.7	43.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.83	2.95	1.95	0.994	0.768
Other Long Term Assets
Total Assets	168	143	94.3	51.8	45.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	11	12.4	11.8	8.88	6.84
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.8	14.6	12.7	8.88	6.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	154	128	81.6	42.9	38.4
Total Liabilities & Shareholders' Equity	168	143	94.3	51.8	45.3
Total Common Shares Outstanding